SALVATICI, ELISABETTA
SALVATICI, ELISABETTA
Universita' degli Studi di MILANO
A new diagnosis of infantile form of alexander disease with a novel DNA mutation of the glial fibrillary acid protein gene (GFAP)
2011 E. Salvatici, R. Selmi, F. Salvini, E. Riva
A specific prebiotic mixture added to starting infant formula has long-lasting bifidogenic effects
2011 F. Salvini, E. Riva, E. Salvatici, G. Boehm, J. Jelinek, G. Banderali, M. Giovannini
Absence of severe recurrent infections in GSD IB
2008 S. Paci, M. Gasparri, I. Giulini Neri, G. Cagnoli, E. Salvatici, M. Giovannini
Alexander disease infantile form presenting with GFAP gene DNA mutation in exon 1 with substitution missense c.715C>T in p.R239C : a case report
2013 E. Salvatici, S. Barberi, F. Salvini, R. Selmi, V. Rovelli, E. Riva
Amino acid status 6 hours after the assumption of two amino acid preparations in PKU patients on diet-therapy
2007 M. Giovannini, D. Casero, S. Paci, M. Gasparri, S. El Oksha, M. Bonza, A.M. Lammardo, E. Salvatici, C. Agostoni
Body composition in schoolchildren in Milan, Italy
2009 M. Giovannini, M. Sala, F. Cetta, M. Bonza, M. Salvioni, M. Mandelli, E. Salvatici, S. Scaglioni
Bone mass density and body composition measured with dexa in patient affected by hyperphenilalaninemia
2009 M. Giovannini, M. Bonza, S. Paci, D. Bertolotti, G. Cagnoli, E. Salvatici, E. Riva
Bone metabolism and hypovitaminosis D in patients affected by glycogen storage disease type I (GSD I)
2011 E. Riva, S. Pieretti, S. Paci, I. Giulini Neri, E. Salvatici, M. Giovannini
Bone mineral density (BMD) in patients affected by hyperphenylalanynemia (HPA) : effects of calcium integration and physical activity evaluated with dual energy x-ray absorptiometry (DEXA)
2011 E. Riva, E. Salvatici, V. Scelsa, G. Cagnoli, S. Vincenti, S. Paci, M. Giovannini
Bone mineralization in type 1 glycogen storage disease: a two years follow up study
2010 E. Riva, I. Giulini Neri, M. Gasparri, J. Scotti Gerber, E. Salvatici, D. Minghetti, G. Cagnoli, S. Paci
Breastfeeding in phenylketonuric (PKU) and hyperphenylalaninemic (HPA) infants : how and why
2012 M. Giovannini, S. Paci, A. Lops, E. Salvatici, E. Verduci, G. Banderali, E. Riva
Breastfeeding in phenylketonuric and hyperphenylalaninemic infants : how and why
2012 M. Giovannini, S. Paci, A. Lops, E. Salvatici, E. Verduci, G. Banderali, E. Riva
Cardiovascular disease (CVD) risk factors in a population of hypercholesterolemic children with genetic diagnosis of heterozgous familial hypercholesterolemia (HEFH)
2013 M. Giovannini, C. Pederiva, M.E. Capra, P.C. Poli, S. Barberi, F. Salvini, E. Riva, E. Salvatici
Cardiovascular risk factors in hyperphenylalaninemic children on dietary treatment : correlation between carotid intima-media thickness and docosaexahenoic acid supplementation
2013 E. Salvatici, C. Pederiva, M.E. Capra, S. Vincenti, S. Paci, M. Giovannini
Case report: GSD type 1. and pregnancy
2008 S. Paci, M. Gasparri, I. Giulini Neri, M. Bonza, E. Salvatici, M. Giovannini
Cerumen : a fundamental but neglected problem by pediatricians
2016 P. Marchisio, C. Pipolo, M. Landi, D. Consonni, N. Mansi, G. Di Mauro, E. Salvatici, P. Di Pietro, S. Esposito, G. Felisati, N. Principi
Could neurological symptomatology precede an acute metabolic crisis in patient affected by propionic aciduria (PA)? A particular case report
2012 S. Paci, S. Vincenti, R. Selmi, E. Salvatici, E. Riva
Densità minerale ossea (BMD) nei pazienti affetti da iperfenilalaninemia (HPA): ruolo della supplementazione con calcio e dell'attività fisica
2011 E. Riva, E. Salvatici, S. Paci, V. Scelsa, S. Vincenti, M. Giovannini
Diagnosticare la malattia di Fabry per curarla
2008 E. Salvatici, M. Bonza, S. Bellini, S. Paci, E. Riva
Dietary glycemic index, glycemic load and metabolic profile in children with phenylketonuria
2017 F. Moretti, N. Pellegrini, E. Salvatici, V. Rovelli, G. Banderali, G. Radaelli, F. Scazzina, M. Giovannini, E. Verduci